Article

High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype

2024-01-31

Abstract excerpt

<title>Abstract</title> <p>Background Breast cancer (BC) is the most common cancer in women and the leading cause of cancer-related death worldwide. This heterogeneous disease has been historically considered a non-immunogenic type of cancer. However, recent advances in immunotherapy have increased the interest in knowing the role of the immune checkpoints (IC) and other immune regulation pathways in this neopla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 912c9567-4b40-5fd8-ad85-7c2508883dab
DOI: 10.21203/rs.3.rs-3903179/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtypeDOI 10.21203/rs.3.rs-3903179/v1Read

Expression Patterns of Immune Checkpoints In Breast Cancer PatientsSemantic proximity Read

Novel Immune Subtypes Identification of HER2 Positive Breast Cancer Based On Immunogenomic LandscapeSemantic proximity Read

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancerSemantic proximity Read

Immune signature of metastatic breast cancer: Identifying predictive markers of immunotherapy response.Semantic proximity Read

Highly immune-related genes of breast cancer: potential diagnostic and prognostic biomarkersSemantic proximity Read

Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable SurvivalSemantic proximity Read

Identification of novel tumor antigens and immune subtypes in breast cancer patients for mRNA vaccine developmentSemantic proximity Read

Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome DataSemantic proximity Read

Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancerSemantic proximity Read

Identification of immune subtypes and response prediction to immune-checkpoint inhibitors for MDM4 gain/amplification luminal A type breast cancerSemantic proximity Read

PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarkerSemantic proximity Read